Hereditary Cancer

Hereditary cancer testing focuses on analyzing specific genes associated with an increased risk of developing hereditary cancers, such as breast, ovarian, colorectal, pancreatic, and prostate cancers. By identifying these genetic mutations, individuals and their healthcare providers can make informed decisions regarding cancer surveillance, preventive measures, and targeted interventions.

Workflow

Products

BRCA

NGS Panel for testing of genetic variants from BRCA1, BRCA2 genes to check potential pathogenic factors regarding to breast and ovarian cancers.

CancerRisk 60

NGS Panel for testing of genetic variants from 60 genes to check potential pathogenic factors regarding to hereditary cancers.

CancerRisk Checkup

NGS Panel for testing of genetic variants from 100 genes to check potential pathogenic factors regarding to hereditary cancer, heart disease and dementia.

Clinical Exome

A powerful genetic testing technique used in clinical medicine to identify genetic variations and mutations within the protein-coding regions of an individual's DNA.